⚕️ Medical Disclaimer: Exosome therapy is a complementary, supportive treatment. It does not cure Parkinson's disease. Always work with a neurologist for your primary care and medication management.
The Mechanism
Targeting Neuroinflammation in Parkinson's
Parkinson's disease involves the progressive loss of dopaminergic neurons in the substantia nigra, driven in large part by chronic neuroinflammation and oxidative stress. iPSC exosomes provide neuroprotective and anti-inflammatory signals that may help slow this cascade.
- Reduces microglial activation and neuroinflammation
- Delivers neuroprotective growth factors (GDNF, BDNF)
- Reduces α-synuclein aggregation in preclinical models
- Crosses the blood-brain barrier effectively
- Supports mitochondrial function in surviving neurons
- May improve motor symptom scores as a complement to medication
